Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Psilocybinは幻覚剤でもありますが, 近年では治療抵抗性うつ病の薬としても注目されています. https://t.co/PX3rBhB76R

@Domovoi_ @wexleresq @ThePhoenixBabe https://t.co/7wv10JUbmD

Psilocybina: de una droga de abuso a una futura terapia para la depresión rebelde al tratamiento. Interesante estudio, dosis semanales protocolizadas Psilocybin with psychological support for treatment-resistant depressi... https://t.co/tzPY5SlCxB https:/

@AlphaSierraP I will try DMT here one day soon. I’m a fan of mushrooms and marijuana. Ketamine too as a medical treatment. 1) https://t.co/CuN4t4DA3U. 2) https://t.co/nii4EJIzTf

Aquí un estudio sobre las aplicaciones de los famosos "Hongos mágicos" en conjunto con soporte psicológico. https://t.co/h6kXaA1BXv.

How psilocybin is not an approved treatment for depression is absolutely beyond me. @RCarhartHarris https://t.co/ubLF18T0pP https://t.co/bPtZnHultQ

https://t.co/hDcdoJLaGK

https://t.co/D78898WVT2

mother nature.. "Psilocybin is a naturally occurring plant alkaloid" https://t.co/vdXpVF7lue

@Matara_jin Here are some studies on the topic if you are interested https://t.co/fim2v75pRx https://t.co/Rtg7Z7t23S Still psychedelics remain dangerous Even with the highest caution you never know where you are going to be taken, it can lead you to a dre

Psilocybin has a novel pharmacological action in comparison with currently available treatments for depression (ie, 5-HT2A receptor agonism) and thus could constitute a useful addition to available therapies for the treatment of depression https://t.co/vft

Johns Hopkins has looked into this in Terminal Cancer Depression. https://t.co/6ubossxQ1q https://t.co/Az8r6nttoD It is time to take a deep dive but first the Cancer story In 2016, I became a green thumb on a mission. My father had stage4 bone mets with

Супстанцата која ја содржат, psilocybin, е најдено дека помага кај депресии кои се отпорни на лекови. Има многу истражувања на темава, еве едно: https://t.co/juI8GHWKjd

@mpigliucci Massimo - this is a good paper in the Lancet (Psychiatry) headed by @RCarhartHarris on this very issue and it was one of the papers that started opening my personal view of them as useful: https://t.co/laXuyjIIp9

@ZBooksTX @BernieToVest @CAZM023 https://t.co/O3w4R9N1Lw

RT @LiquidLifeBC: In the following study, researchers assessed the potential of #Psilocybin (#MagicMushrooms) to treat depression. Using on…

RT @LiquidLifeBC: In the following study, researchers assessed the potential of #Psilocybin (#MagicMushrooms) to treat depression. Using on…

RT @LiquidLifeBC: In the following study, researchers assessed the potential of #Psilocybin (#MagicMushrooms) to treat depression. Using on…

In the following study, researchers assessed the potential of #Psilocybin (#MagicMushrooms) to treat depression. Using only 2 doses, 67% reported complete remission at week 1. And 42% remained in full remission at 3 months. ✨🍄✨🍄✨🍄✨🍄✨🍄✨https://t.co/gYdiBcqZ

Challenge 4: This article in the Lancet has shown that psilocybin has managed to decrease QIDS depression scores with significant results within just a week! https://t.co/Kg9TJlWbNu @TessTsindos @Monash_SPHPM @PennyRobaus @BasiaDiug #BMS1042

RT @voteyeson109: Measure 109 builds on numerous research studies conducted at leading institutions and creates a legal, licensed, and safe…

Measure 109 builds on numerous research studies conducted at leading institutions and creates a legal, licensed, and safe program for psilocybin therapy. Learn more at https://t.co/2gLORMtyfs. To read the full study referenced in the graphic click here: h

And we get 7 years for possessing this drug. Thank You @MaajidNawaz Top work my friend✌️

Thank You @lbc @MaajidNawaz for bringing this to our attention as we build our project & objectives. #THFC #MentalHealthAwareness #MentalHealthMatters https://t.co/JY6Bxzy2Hy

RT @MaajidNawaz: To anyone listening to my @LBC show now on the positive effects of psilocybin (found in “magic” mushrooms) for treating de…

For all those currently listening to @LBC @MaajidNawaz RE: Depession PTSD treatment. I believe this is the article - https://t.co/2ZGWTotfil #MentalHealthMatters #MentalHealthAwareness ✌️

@mverbora @PattyHajdu Quick pub med shows potential to help w/ treatment resistant depression, anxiety, PTSD, OCD, & more: https://t.co/vNMZWtO39Z https://t.co/drUG5pQNQg https://t.co/bRlBcIy69n https://t.co/uS99A4Abuf Researchers suggest removing

RT @LiquidLifeBC: In the search for a therapeutic to address treatment-resistant depression, #psilocybin (magic mushrooms) may prove to be…

RT @LiquidLifeBC: In the search for a therapeutic to address treatment-resistant depression, #psilocybin (magic mushrooms) may prove to be…

RT @LiquidLifeBC: In the search for a therapeutic to address treatment-resistant depression, #psilocybin (magic mushrooms) may prove to be…

In the search for a therapeutic to address treatment-resistant depression, #psilocybin (magic mushrooms) may prove to be a viable solution. In the following study, psilocybin reduced depression, anxiety and anhedonia. 🍄 https://t.co/gYdiBcqZk0

@jaxelinha @balloccoo https://t.co/XcsJPZY5PA

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

Full-text pdf: https://t.co/l1BKWdajCx @TheDailyShroom https://t.co/CqOGRHusFC

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

🗣🗣🗣🗣🗣@HighlyOptimize

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

#psilocybin #research on treatment-resistant #depression study As we survive and cope during this inevitable economic recession, it’s imperative that these natural alternatives become accessible for healing depression and trauma. Personal use should be de

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

Right on Doc @drmikehart ! #TogetherWeWILL https://t.co/ndwQgSgInZ xx

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

RT @drmikehart: 12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms)…

12 patients (six men and women) with treatment-resistant depression received 10mg and 25mg of psilocybin (magic mushrooms) 7 days apart in a supportive setting. Depression and anxiety scores were markedly reduced at 1 week and on a 3-month follow-up. h

@hazelinha Hay muchos reportes en la comunidad científica al respecto. https://t.co/3t8hluFnA1

@AliakbarAbolha1 @Sina_Thr https://t.co/WRBAWmyniQ

Psilocybin CAN help depression. https://t.co/M9Ipdq8fJs

@SnippyLady @Miles_Tarbox @caravsx Miles point is certainly valid. See https://t.co/UhEHE7qrvJ. In fairness, one must consider with a critical mindset. It's promising but no panacea. Nothing is with mental illness.

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study - ScienceDirect https://t.co/z4efIxjd2t

@joarhalvorsen @H_Grostad 1. Personer med behandlings-resistent depresjon viser en tydelig forbedring etter inntak av psilocybin i en terapeutisk kontekst. https://t.co/oANcaeHw3U

@MJA_Editor 1st ep covers psilocybin (magic mushrooms), Open-label study with people whose depression had failed to respond to standard treatments showed some improvements ...more research needed but a topic worthy of investigation? disclaimer i haven't se

@andreas_wahl @dagfinnhessenp " Relative to baseline, depressive symptoms were markedly reduced 1 week (mean QIDS difference –11·8, 95% CI –9·15 to –14·35, p=0·002, Hedges’ g=3·1) and 3 months (–9·2, 95% CI –5·69 to –12·71, p=0·003, Hedges’ g=2) after high

https://t.co/CJn1zp4E5a

RT @emigrl: ランセットのマジックマッシュルームを使った鬱病治療の報告これね https://t.co/zGUcDzhbtB まだまだ研究が必要だけど、期待ができる。

RT @m_wall: @AllenFrancesMD @neuroraf Perhaps you'd consider trying psychedelic-assisted psychotherapy first? Very effective (early days fo…

@AllenFrancesMD @neuroraf Perhaps you'd consider trying psychedelic-assisted psychotherapy first? Very effective (early days for trials, but it's hopeful) and less invasive/fewer side effects. https://t.co/XSbNiY5SIy

@Okiedokie02 https://t.co/UexIPS4v3G

Psilocybin with psychological support for treatment-resistant depressi... https://t.co/UexIPS4v3G

RT @MAPSCanada: #Psilocybin with psychological support for treatment-resistant #depression: open-label study, investigates the feasibility,…

RT @MAPSCanada: #Psilocybin with psychological support for treatment-resistant #depression: open-label study, investigates the feasibility,…

RT @MAPSCanada: #Psilocybin with psychological support for treatment-resistant #depression: open-label study, investigates the feasibility,…

RT @MAPSCanada: #Psilocybin with psychological support for treatment-resistant #depression: open-label study, investigates the feasibility,…

RT @MAPSCanada: #Psilocybin with psychological support for treatment-resistant #depression: open-label study, investigates the feasibility,…

RT @MAPSCanada: #Psilocybin with psychological support for treatment-resistant #depression: open-label study, investigates the feasibility,…

@MAPSCanada @RCarhartHarris @ProfDavidNutt @MendelKaelen Full-text pdf: https://t.co/nb2IXtnOU4 @Chacruna_net @hellopsillow @APRA_bot @BeckleyResearch

RT @MAPSCanada: #Psilocybin with psychological support for treatment-resistant #depression: open-label study, investigates the feasibility,…

#Psilocybin with psychological support for treatment-resistant #depression: open-label study, investigates the feasibility, safety & efficacy in patients with treatment-resistant depression. #BeckleyImperial @RCarhartHarris @ProfDavidNutt @MendelKaelen

Eens ✅ Maar... wél onder begeleiding, en niet voor de meute!

@strvrw @Merlijn65761540 @Vera_Bergkamp Drugs kunnen best geschikt zijn voor mensen. Zie bijv. https://t.co/1M0SIECroU, https://t.co/NIgrnuckGf, en https://t.co/uCMMN45apA. Onderzoek wordt zwaar belemmerd door de juridische status, ondanks veelbelovendheid

Psilocybin with psychological support for treatment-resistant depressi... https://t.co/Nbn1NJZ5eV

Researchers suggest removing schedule 1 classification for Psilocybin #Magic #mushroom https://t.co/WobeJBjJJh Quick pub med shows potential for: #treatment resistant #depression #PTSD #OCD #scicomm https://t.co/vNMZWtO39Z https://t.co/drUG5pQNQg http

@drkeithscott John Hopkins researchers suggest removing schedule 1 classification for #Magic #mushroom https://t.co/WobeJBjJJh Quick pub med shows potential for: #treatment resistant #depression #PTSD #OCD #scicomm https://t.co/vNMZWtO39Z https://t.co/

@AOC Thank you @AOC Psilocybin with psychological support for treatment-resistant depressi... https://t.co/IiIVdIy4bc

Sounds radical and I can imagine it feeding into culture warring but it's just eminently sensible policy, with further research more than supported by the evidence (e.g. https://t.co/gWbORzId4A; https://t.co/4pErdYOeRq; https://t.co/gn71Fr2NLU)

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study https://t.co/htBd5IS1Rn

@pinkyrosin https://t.co/9c7s7rwKDb

The open access Lancet Psych article is here: https://t.co/20Sf7Hbspb

@AntLiveOfficial @TheLSDBlotter So much research going on. I was at a talk by ketamine researchers a few weeks ago; they are doing therapy and research and about to release a second book about it. This research from 2016 on psilocybin & depression is r

Cogumelos psicodélicos apresentam ótimos resultados contra sintomas de depressão. ❤️🍄 #psychedelic #freelula #mariellefranco #depression https://t.co/yh5f7HunZ0

RT @NicholasJohn83: John Hopkins researchers suggest removing schedule 1 classification for #Magic #mushroom https://t.co/WobeJBjJJh Quick…

RT @Kztk_2: マジックマッシュルームの成分であるPsilocybinを、治療抵抗性のうつ病患者へ投与したところ、３週間後に寛解に達したというlancet掲載論文。 https://t.co/eM37nFg5VV

RT @NicholasJohn83: John Hopkins researchers suggest removing schedule 1 classification for #Magic #mushroom https://t.co/WobeJBjJJh Quick…

John Hopkins researchers suggest removing schedule 1 classification for #Magic #mushroom https://t.co/WobeJBjJJh Quick pub med shows potential for: #treatment resistant #depression #PTSD #OCD #scicomm https://t.co/vNMZWtO39Z https://t.co/drUG5pQNQg ht

RT @annatessrickman: @CharlesFLehman @LeoBeletsky @RCarhartHarris @TEDx https://t.co/ui78zPgNwB

RT @DayanaHappyBody: Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study - The Lancet…

RT @HaKoSeMi: 面白い論文。匙加減次第で毒にも薬にもなるって医学らしくていいですね。 https://t.co/Z44w626iUh

RT @HaKoSeMi: 面白い論文。匙加減次第で毒にも薬にもなるって医学らしくていいですね。 https://t.co/Z44w626iUh

RT @Kztk_2: マジックマッシュルームの成分であるPsilocybinを、治療抵抗性のうつ病患者へ投与したところ、３週間後に寛解に達したというlancet掲載論文。 https://t.co/eM37nFg5VV

RT @Kztk_2: マジックマッシュルームの成分であるPsilocybinを、治療抵抗性のうつ病患者へ投与したところ、３週間後に寛解に達したというlancet掲載論文。 https://t.co/eM37nFg5VV